Unknown

Dataset Information

0

GM-CSF Enhances Macrophage Glycolytic Activity In Vitro and Improves Detection of Inflammation In Vivo.


ABSTRACT: UNLABELLED:(18)F-FDG accumulates in glycolytically active tissues and is known to concentrate in tissues that are rich in activated macrophages. In this study, we tested the hypotheses that human granulocyte-macrophage colony-stimulating factor (GM-CSF), a clinically used cytokine, increases macrophage glycolysis and deoxyglucose uptake in vitro and acutely enhances (18)F-FDG uptake within inflamed tissues such as atherosclerotic plaques in vivo. METHODS:In vitro experiments were conducted on human macrophages whereby inflammatory activation and uptake of radiolabeled 2-deoxyglucose was assessed before and after GM-CSF exposure. In vivo studies were performed on mice and New Zealand White rabbits to assess the effect of GM-CSF on (18)F-FDG uptake in normal versus inflamed arteries, using PET. RESULTS:Incubation of human macrophages with GM-CSF resulted in increased glycolysis and increased 2-deoxyglucose uptake (P < 0.05). This effect was attenuated by neutralizing antibodies against tumor necrosis factor-? or after silencing or inhibition of 6-phosphofructo-2-kinase. In vivo, in mice and in rabbits, intravenous GM-CSF administration resulted in a 70% and 73% increase (P < 0.01 for both), respectively, in arterial (18)F-FDG uptake in atherosclerotic animals but not in nonatherosclerotic controls. Histopathologic analysis demonstrated a significant correlation between in vivo (18)F-FDG uptake and macrophage staining (R = 0.75, P < 0.01). CONCLUSION:GM-CSF substantially augments glycolytic flux in vitro (via a mechanism dependent on ubiquitous type 6-phosphofructo-2-kinase and tumor necrosis factor-?) and increases (18)F-FDG uptake within inflamed atheroma in vivo. These findings demonstrate that GM-CSF can be used to enhance detection of inflammation. Further studies should explore the role of GM-CSF stimulation to enhance the detection of inflammatory foci in other disease states.

SUBMITTER: Singh P 

PROVIDER: S-EPMC5093920 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

GM-CSF Enhances Macrophage Glycolytic Activity In Vitro and Improves Detection of Inflammation In Vivo.

Singh Parmanand P   González-Ramos Silvia S   Mojena Marina M   Rosales-Mendoza César Eduardo CE   Emami Hamed H   Swanson Jeffrey J   Morss Alex A   Fayad Zahi A ZA   Rudd James H F JH   Gelfand Jeffrey J   Paz-García Marta M   Martín-Sanz Paloma P   Boscá Lisardo L   Tawakol Ahmed A  

Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20160414 9


<h4>Unlabelled</h4>(18)F-FDG accumulates in glycolytically active tissues and is known to concentrate in tissues that are rich in activated macrophages. In this study, we tested the hypotheses that human granulocyte-macrophage colony-stimulating factor (GM-CSF), a clinically used cytokine, increases macrophage glycolysis and deoxyglucose uptake in vitro and acutely enhances (18)F-FDG uptake within inflamed tissues such as atherosclerotic plaques in vivo.<h4>Methods</h4>In vitro experiments were  ...[more]

Similar Datasets

| S-EPMC7037240 | biostudies-literature
| S-EPMC7351110 | biostudies-literature
| S-EPMC2584818 | biostudies-other
| S-EPMC7605919 | biostudies-literature
| S-EPMC4446881 | biostudies-literature
| S-EPMC4733039 | biostudies-literature
| S-EPMC3683787 | biostudies-literature
2023-10-02 | GSE217893 | GEO